NCT04653493 2021-03-19
CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)
Sabz Biomedicals
Phase 1 Unknown
Sabz Biomedicals
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Peking Union Medical College Hospital
National Cancer Institute (NCI)